Ivan Rosenberg

This inventor holds 10 USPTO granted patents and 2 published patent applications, plus 4 CIPO patents and 3 EPO patents. Top assignees: Institute of Organic Chemistry and Biochemistry, Ceskoslovenska Akademie Ved, Rega Stichting, V.z.w.. Active years: 1987-2022.

USPTO Granted Patents = 10 (Patent Applications = 2)

% Patents Active = 100.0

CIPO Patents = 4

EPO Patents = 3 (Patent Applications = 5)

Average Co-Inventor Count = 3.3

ph-index = 6

Forward Citations = 324(Granted Patents)

Location History:

Obrancu min, CZ (1988)
Praha, CZ (1989 - 1992)
Prague, CZ (1987 - 2022)

Company Filing History:

6 out of 50

Institute of Organic Chemistry and Biochemistry

patents

4 out of 242

Ceskoslovenska Akademie Ved

patents

2 out of 21

Rega Stichting, V.z.w.

where one patent can have more than one assignee

Years Active: 1987-2022

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11292812 - 3'3′-cyclic dinucleotides (2022-04-05),

2. 11203610 - 2'3′ cyclic dinucleotides with phosphonate bond activating the sting adaptor protein (2021-12-21),

3. 11149052 - 2'3′-cyclic dinucleotides (2021-10-19),

4. 10966999 - 3'3′ cyclic dinucleotides with phosphonate bond activating the sting adaptor protein (2021-04-06),

5. 5869467 - 9-(2-phosphonylmethoxyethyl) guanine (1999-02-09),

6. 5641763 - N-phosphonylmethoxyalkyl derivatives of pyrimdine and purine bases and a (1997-06-24),

7. 5142051 - N-phosphonylmethoxyalkyl derivatives of pyrimidine and purine bases and (1992-08-25),

8. 4808716 - 9-(phosponylmethoxyalkyl) adenines, the method of preparation and (1989-02-28),

9. 4724233 - Therapeutical application of phosphonylmethoxyalkyl adenines (1988-02-09),

10. 4659825 - Isomeric O-phosphonylmethyl derivatives of enantiomeric and racemic (1987-04-21),

Title: Ivan Rosenberg: Innovator in Nucleotide Analogues

Introduction

Ivan Rosenberg is a notable inventor based in Prague, Czech Republic. He has made significant contributions to the field of nucleotide analogues, with a total of 10 patents to his name. His work focuses on developing biologically active compounds that have potential applications in antiviral therapies.

Latest Patents

Among his latest patents is the invention of 9-(2-phosphonylmethoxyethyl) guanine. This invention addresses the technical problem of utilizing new nucleotide analogues as biologically active compounds. The subject of this patent includes N-(2-phosphonylmethoxyethyl) and N-(3-hydroxy-2-phosphonylmethoxypropyl) derivatives of pyrimidine and purine bases. These derivatives are easily accessible from heterocyclic bases and their N-(2-hydroxyethyl) or N-(2,3-dihydroxypropyl) derivatives. Some of the compounds described in this invention exhibit marked antiviral activity or can be transformed into active compounds through chemical processes.

Career Highlights

Ivan Rosenberg has worked with prestigious institutions such as the Czech Academy of Sciences and the Institute of Organic Chemistry and Biochemistry of the Academy of Sciences. His research has significantly advanced the understanding and application of nucleotide analogues in medicinal chemistry.

Collaborations

Throughout his career, Ivan has collaborated with esteemed colleagues, including Antonin Holy and Erik D De Clercq. These collaborations have further enriched his research and contributed to the development of innovative solutions in his field.

Conclusion

Ivan Rosenberg's contributions to the field of nucleotide analogues highlight his role as a key innovator in the scientific community. His patents and collaborations reflect a commitment to advancing antiviral therapies through innovative research.